$ cat molecule-index.md
# Molecule Index
> Same ingredient. Different brand. Different country. Different price.
Source-backed medicine price notes for the drugs we can verify now; ingredient-first index for the rest.
Malachite Green Ox o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Protomor
Malachite Green Oxalate, Ethacridine Lactate, Methylene Blue Anhydrous, Gentian Violet · Oral
Copper Sulfate Pen o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Dessamor
Copper Sulfate Pentahydrate, Ethacridine Lactate, Methylene Blue Anhydrous · Oral
Methylene Blue Cry o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Methylene Blue Crystal
Methylene Blue Crystal · Oral
Methylene Blue Tri o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Methylene Blue Trihydrate
Methylene Blue Trihydrate · Oral
Glutaral And Methy o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Stressguard Liquid
Glutaral And Methylene Blue · Oral
Methenamine, Pheny o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Vilamit Mb
Methenamine, Phenyl Salicylate, Sodium Phosphate, Monobasic, Anhydrous, Methylene Blue Anhydrous, And Hyoscyamine Sulfat · Oral
Methenamine, Pheny o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Vilevev Mb
Methenamine, Phenyl Salicylate, Sodium Phosphate, Monobasic, Anhydrous, Methylene Blue Anhydrous, And Hyoscyamine Sulfat · Oral
Methenamine, Sodiu o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Uroav-81
Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue And Hyoscyamine Sulfate · Oral
Methenamine, Sodiu o--o \/ /\ o--o
:| molecule · DailyMed SPL index
Uroav-B
Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue And Hyoscyamine Sulfate · Oral
$ cat method.md
Ingredient first, prices second
Now
Index 100,000 drug/package records by active ingredient, brand, route, class hint, source, and risk/price-gap watch signals.
Next
Attach daily country snapshots for US, Canada, UK, India, Mexico, and EU comparator markets.
Later
Track pharmacy-level prices, coupons, cash-pay providers, generic availability, and verified substitution boundaries.